对39例中晚期肝癌采用同步化疗栓塞肝动脉和门静脉取得满意疗效。分别采用经腹双置管栓塞术(31例),介入双栓术(8例)。介入双栓术具有:可了解肿瘤范围,肿瘤血管分布及栓塞剂走向,且创伤小。但需借助高新医疗器械,且不能保留栓塞导管进行再次栓塞。剖腹置管双栓优点为:探明腹腔内病变,术中可取活检,了解肝硬化门脉高压情况,医疗器械需求简单和术后可保留插管反复栓塞。但仍有创伤大,术后肝门粘连之弊。 For 39 cases of advanced liver cancer, synchronous hepatic artery embolization of hepatic artery and portal vein achieved satisfactory results. Trans-abdominal double-tube embolization (31 cases) and interventional double embolization (8 cases) were used. The interventional double embolectomy has the advantages of understanding the tumor range, tumor blood vessel distribution and embolic agents’ direction, and having less trauma. However, high-tech medical devices are needed and embolization catheters cannot be re-embolized. Caesarean section tube double suppository advantage is: to explore intraperitoneal lesions, intraoperative biopsy, to understand the cirrhosis portal hypertension, medical equipment needs simple and postoperative can be retained after repeated intubation embolization. However, there are still serious wounds and the disadvantages of postoperative hepatic hilar adhesions.